Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.44
Delayed Data
As of May 24
 +0.49 / +4.47%
Today’s Change
6.36
Today|||52-Week Range
19.96
+8.54%
Year-to-Date

Today’s Trading

Previous close10.95
Today’s open11.01
Day’s range10.96 - 11.67
Volume1,271,384
Average volume (3 months)697,516
Market cap$1.2B
Dividend yield8.75%
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+438.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.94+3.53%
ACHNAchillion Pharmaceut...+0.40+4.71%
ALDRAlder Biopharmaceuti...+0.79+2.87%
CLLSCellectis SA-0.01-0.03%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs